AR009523A1 - Derivado de pirimidina 2,4-disustituida, procedimiento para preparar el mismo y una composicion farmaceutica que lo contiene. - Google Patents

Derivado de pirimidina 2,4-disustituida, procedimiento para preparar el mismo y una composicion farmaceutica que lo contiene.

Info

Publication number
AR009523A1
AR009523A1 ARP970104019A ARP970104019A AR009523A1 AR 009523 A1 AR009523 A1 AR 009523A1 AR P970104019 A ARP970104019 A AR P970104019A AR P970104019 A ARP970104019 A AR P970104019A AR 009523 A1 AR009523 A1 AR 009523A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
disorders
disstituted
pirimidine
prepare
Prior art date
Application number
ARP970104019A
Other languages
English (en)
Spanish (es)
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of AR009523A1 publication Critical patent/AR009523A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP970104019A 1996-09-04 1997-09-03 Derivado de pirimidina 2,4-disustituida, procedimiento para preparar el mismo y una composicion farmaceutica que lo contiene. AR009523A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25542096 1996-09-04

Publications (1)

Publication Number Publication Date
AR009523A1 true AR009523A1 (es) 2000-04-26

Family

ID=17278521

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104019A AR009523A1 (es) 1996-09-04 1997-09-03 Derivado de pirimidina 2,4-disustituida, procedimiento para preparar el mismo y una composicion farmaceutica que lo contiene.

Country Status (5)

Country Link
AR (1) AR009523A1 (id)
AU (1) AU4134297A (id)
ID (1) ID17076A (id)
WO (1) WO1998009960A1 (id)
ZA (1) ZA977427B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432947B1 (en) 1997-02-19 2002-08-13 Berlex Laboratories, Inc. N-heterocyclic derivatives as NOS inhibitors
JP2002241369A (ja) * 1998-05-18 2002-08-28 Dainippon Pharmaceut Co Ltd ４−ピリミジニルアミノアセトアミド誘導体及びそれを含有する医薬組成物
AU2004200A (en) * 1999-01-14 2000-08-01 Meiji Seika Kaisha Ltd. Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
WO2001036392A1 (fr) 1999-11-17 2001-05-25 Dainippon Pharmaceutical Co., Ltd. Derives de [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide, procede de production desdits composes, compositions medicinales contenant ces composes et produit intermediaire de ces composes
US6525051B2 (en) 2000-03-27 2003-02-25 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
DE60236322D1 (de) * 2001-12-07 2010-06-17 Vertex Pharma Verbindungen auf pyrimidin-basis als gsk-3-hemmer
US6982259B2 (en) 2002-04-30 2006-01-03 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
JP4800216B2 (ja) * 2003-10-24 2011-10-26 エグゼリクシス， インコーポレイテッド ｐ７０Ｓ６キナーゼモジュレーターおよび使用方法
EP1939181A1 (en) * 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
JP5642973B2 (ja) * 2007-03-22 2014-12-17 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ Ｊａｋ阻害薬として有用なｎ−複素環式化合物
GB0808664D0 (en) * 2008-05-13 2008-06-18 Syngenta Ltd Chemical compounds
US8691866B2 (en) 2008-12-10 2014-04-08 The General Hospital Corporation HIF inhibitors and use thereof
US8586751B2 (en) 2009-06-12 2013-11-19 Bristol-Myers Squibb Company Nicotinamide compounds useful as kinase modulators
US20220251104A1 (en) * 2018-11-30 2022-08-11 Celularity Inc. Aromatic compounds for use in activating hematopoietic stem and progenitor cells
CN115551840A (zh) * 2020-05-19 2022-12-30 优迈特株式会社 含氟嘧啶化合物和含氟嘧啶酮化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710874A (ja) * 1993-04-28 1995-01-13 Dainippon Pharmaceut Co Ltd ３−（１，２，４−オキサジアゾリル）−５，６，７，８−テトラヒドロ−１，６−ナフチリジン誘導体
JPH07165721A (ja) * 1993-12-15 1995-06-27 Sumitomo Chem Co Ltd 放射性イソキノリンカルボキサミド誘導体

Also Published As

Publication number Publication date
ID17076A (id) 1997-12-04
ZA977427B (en) 1998-03-02
AU4134297A (en) 1998-03-26
WO1998009960A1 (fr) 1998-03-12

Similar Documents

Publication Publication Date Title
AR009523A1 (es) Derivado de pirimidina 2,4-disustituida, procedimiento para preparar el mismo y una composicion farmaceutica que lo contiene.
AR023823A1 (es) Compuestos derivados de piperazina utiles como antagonistas ccr5, composiciones farmaceuticas que los comprenden, y el uso de los mismos para la preparacion de medicamentos.
PE27499A1 (es) Derivados del 2-(purin-9-il)-tetrahidrofuran-3,4-diol
DE69724777D1 (de) Pentafluorobenzensulfonamiden und analoge
GT199900128A (es) 1-aril-3-arilmetil-1,8-naftiridin-4(1h)-onas
EA199700203A1 (ru) Синергические комбинации зидовудина, 1592u89 и 3тс или ftc
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
PT1259489E (pt) Compostos azapoliciclicos condensados con arilo.
DE60205564D1 (de) N-Adamantylalkyl Benzamide Derivativen als p2x7-rezeptor antagonisten
LV12568A (en) Morpholine and thiomorpholine tachykinin receptor antagonists
AP2004003028A0 (en) Benzamide and heteroarylamide as P2X7 receptor antagonists
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
DE60041763D1 (de) Inhibitoren von c-jun n-terminal kinasen (jnk)
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
KR910018381A (ko) 개선된 에르골린-8-카복스아미드
FI905957A (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
BG102080A (en) Amino acid derivatives of substituted quinoxalin 2,3-dion derivatives such as glutamate receptor antagonists
ATE152708T1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
DK671087A (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
EA200401297A1 (ru) Замещенные производные аминоизоксазолина и их применение в качестве антидепрессантов
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69904519T2 (de) Sulfonamid-Derivate
HUP0302521A2 (hu) Neurotrop tacrolimus analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE68919280T2 (de) Alpha-adrenergische Rezeptorantagonisten.